January 16, 2025 - 19:43

The latest retail sales report for December indicates a slower-than-anticipated growth, raising concerns among investors about the overall health of consumer spending. As the Federal Reserve prepares to maintain elevated interest rates for an extended period, these figures are particularly significant. The report shows that while December sales did increase, the growth was less robust than analysts had predicted, suggesting a potential cooling in consumer demand.
In contrast, November's sales figures have been revised upward, providing a somewhat brighter picture of the previous month. This adjustment may reflect a stronger-than-expected holiday shopping season, yet it does not fully alleviate concerns regarding the current economic climate. The mixed signals from these reports highlight the challenges faced by retailers and the broader economy as consumers navigate rising costs and shifting spending habits. Investors will be keenly observing future trends as they assess the implications for monetary policy and economic stability.
September 25, 2026 - 03:52
Campaign Finance Complaint Against Let's Go Washington DismissedA campaign finance complaint filed against the political action committee Let`s Go Washington has been dismissed after investigators found no evidence of unreported contributions tied to media...
September 24, 2026 - 22:27
Capital One Financial Corporation to Webcast Conference Call on Third Quarter 2026 EarningsMCLEAN, Va., September 24, 2026 -- Capital One Financial Corporation will report its third quarter 2026 financial results on Tuesday, October 20, 2026. The earnings release is scheduled for...
September 24, 2026 - 04:32
Federal Student Aid Forms for 2027-2028 Released Ahead of ScheduleThe U.S. Department of Education announced Wednesday that the Free Application for Federal Student Aid forms for the 2027-2028 academic year are now available. The release marks an earlier timeline...
September 23, 2026 - 09:02
VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users?Viking Therapeutics has seen its stock outperform major competitors Eli Lilly and Novo Nordisk this month after releasing promising data on its experimental obesity treatment. The results have...